scholarly article | Q13442814 |
P356 | DOI | 10.1093/ANNONC/MDX684 |
P698 | PubMed publication ID | 29077846 |
P50 | author | Koji Izutsu | Q73006741 |
Ritsuro Suzuki | Q73090383 | ||
Eric Tse | Q73119972 | ||
P2093 | author name string | S J Kim | |
S S Chuang | |||
Y S Lee | |||
W S Kim | |||
Y L Kwong | |||
N Schmitz | |||
S Y Oh | |||
C Suh | |||
H J Shin | |||
S R Lee | |||
S T Lim | |||
F d'Amore | |||
Y R Do | |||
A Jaccard | |||
H S Eom | |||
J Y Kwak | |||
T Relander | |||
Y C Mun | |||
P433 | issue | 1 | |
P921 | main subject | chemoradiotherapy | Q5090613 |
P304 | page(s) | 256-263 | |
P577 | publication date | 2017-10-24 | |
P1433 | published in | Annals of Oncology | Q326122 |
P1476 | title | Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma | |
P478 | volume | 29 |
Q55283069 | A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. |
Q90510592 | Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG) |
Q64269086 | Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma |
Q97557982 | First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG |
Q49721392 | NK/T Cell Lymphoma: Updates in Therapy |
Q47548002 | Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas |
Q99564958 | Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study |
Q64081516 | Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma |
Q90171240 | Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making |
Q92675485 | What we should know about natural killer/T-cell lymphomas |
Search more.